Bond funds are subject to interest rate risk, which is the chance bond prices. overall will decline because of rising interest rates, and credit risk, which is the chance a bond issuer will. fail to pay interest and principal in a timely manner or that negative perceptions of the issuerâs ability to.
New Drug Treatment for IBS in Women. NOTE: On March 30, 2007 the FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable bowel syndrome with constipation and for patients younger than 65 years of age with chronic constipation.
LINZESS Â® (linaclotide) is a prescription medication used in adults to treat irritable bowel syndrome with constipation (IBSâC) and chronic idiopathic constipation (CIC). Idiopathic means the cause of the constipation is unknown. It is not known if LINZESS is safe and effective in children less than 18 years of age.